234
Participants
Start Date
December 27, 2023
Primary Completion Date
December 30, 2025
Study Completion Date
January 24, 2026
Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine)
in addition of standard post-CA as the control group, patients will receive an IV high-dose vit-C 50mg/kg infusion every 6 hours, started within the hour after randomization, for 3 days. In addition, all patients will receive intravenous thiamine 200 mg twice a day for 3 days to limit the oxalate production.
standard treatment
no intervention Standard IV vit-C supplementation will be allowed for dosages up to 1000 mg a day from day 4 after randomization, as well as thiamin supplementation.
NOT_YET_RECRUITING
Centre Hospitalier de LENS, Lens
ACTIVE_NOT_RECRUITING
Centre Hospitalier Béthune, Béthune
NOT_YET_RECRUITING
Hôpital Lariboisière, Paris
ACTIVE_NOT_RECRUITING
Centre Hospitalier Universitaire d'Amiens, Amiens
RECRUITING
Centre Hospitalier de Dieppe, Dieppe
RECRUITING
GHEF Site Marne La Vallée, Jossigny
RECRUITING
Centre Hospitalier Universitaire de LILLE, Lille
ACTIVE_NOT_RECRUITING
Centre Hospitalier de Rouen, Rouen
RECRUITING
Centre Hospitalier Toulon La Seyne sur Mer, Toulon
ACTIVE_NOT_RECRUITING
Centre Hospitalier de Valenciennes, Valenciennes
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
OTHER
University Hospital, Lille
OTHER
Centre Hospitalier de Bethune
NETWORK